Queen Elizabeth II fought cancer in secret during her final years, reveals Prince Philip’s friend in new book
Late Queen Elizabeth II would have likely suffered from chronic bone pain due to the malignancy in the latter year of her life.

A future biography of Her Majesty authored by a close friend of Prince Philip stated that the Queen had bone marrow cancer, with bone pain being the most prevalent symptom. The remarks concerning her health problems were made in Gyles Brandreth's planned book, Elizabeth: An Intimate Portrait.
The Queen's death certificate, issued in September, said she died of old age.
Mr Brandreth wrote in the biography, which is being serialised in the Daily Mail that he had heard the Queen had a form of myeloma, a bone marrow cancer, which would explain her tiredness and weight loss, as well as the mobility issues' we were frequently told about during her final year or so of life. Myeloma's most prevalent symptom is bone pain, particularly in the pelvis and lower back, and multiple myeloma is a disease that primarily affects the elderly.
He noted that there is presently no known cure, but therapy, such as medications to control the immune system and pharmaceuticals to help prevent bone weakness, can lower the severity of the symptoms and extend the patient's survival by months or two to three years.
FAQs
Who was Prince Philip?
Queen Elizabeth II was married to Prince Philip, Duke of Edinburgh. As so, he was the British monarch's consort from Elizabeth's coronation on 6 February 1952 until he died in 2021, making him the longest-serving royal consort in history.
Why did Elizabeth make Philip the prince?
Prince Philip did not hold the title of the king since, according to British royal custom, a man who marries into the royal family does not inherit the male form of his wife's title.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.